Overview

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To look at the cognitive effects of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder. To examine the safety, effectiveness and tolerability of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Bristol-Myers Squibb
Treatments:
Aripiprazole